RECURRENT PSYCHOTIC EPISODES FOLLOWING COVID-19 VACCINATION: A CASE REPORT

Abstract Background Acute neuropsychiatric symptoms induced by COVID-19 vaccination have been reported in several cases. Limbic encephalitis stands as one of the differential diagnoses due to its varied manifestations and etiologies making the diagnosis more challenging. Aims & Objectives We present a case that experienced recurrent brief psychotic symptoms and behavior changes with positive image findings following multiple doses of the Moderna COVID vaccine suggesting limbic encephalitis as a potential differential diagnosis. Method We present a case of a 55-year-old man with a history of end-stage renal disease undergoing hemodialysis, and a history of heavy daily alcohol consumption abstaining for 10 years. After receiving the first dose of the Moderna COVID vaccine, he developed acute onset psychotic symptoms characterized by grandiose delusions, vivid auditory and visual hallucinations, and hearing conversations about his alleged past life as a great poet from the 17th century who authored an enduring masterpiece. He remained capable of self-care but exhibited self-talking behaviors. The symptoms completely resolved within 2 weeks without any medication. The patient attributed the symptoms to a spiritual experience and continued to receive subsequent vaccine doses. These symptoms recurred in the same pattern lasting 2-4 weeks after receiving the second and third doses of the Moderna vaccine one month and five months after the initial dose. Around 6 months after the last dose, the patient experienced a similar recurrence of psychotic symptoms, with behavior disturbances which were accident proneness by self-talking on a busy road. A mild, non-febrile upper respiratory tract infection was identified as a possible triggering factor, with normal blood tests. A brain magnetic resonance imaging revealed some old lacunar infarctions and symmetric hyperintensities in the mesial temporal lobe on T2 FLAIR. CSF showed normal in routine analysis and EEG was unremarkable. He demonstrated complete orientation and focused conversation but continued to experience auditory hallucinations and remained firmly convinced of his delusions upon psychiatric visit without focal neurologic signs or abnormal movements. Serum and CSF autoantibody testing were declined and he received treatment with risperidone 1mg per day. The symptoms completely disappeared one week later. Discussion & Conclusion Psychosis following COVID vaccination has been previously reported, but recurrent episodes after each administration have not been documented. Possible mechanisms may involve cytokines crossing the blood-brain barrier leading to acute neuroinflammation. The image findings and the polyphasic course make limbic encephalopathy the primary consideration of differential diagnoses. COVID vaccine-related autoimmune encephalitis has been reported but only in cases with a single episode. Other differential diagnoses to consider include acute disseminated encephalomyelitis (ADEM), and reversible cerebral vasoconstriction syndrome but lacks corresponding imaging evidence. References 1Albsheer, K., Fadul, A., Abdalla, E., Mohamed, G., Elawad, M. Zafar, A. 2022. Post-COVID-19 Vaccine Limbic Encephalitis: A Case Report. Cureus, 14, e29003. 2.Bobot, M. A.-O., Thomas, L., Moyon, A., Fernandez, S., McKay, N., Balasse, L., Garrigue, P. A.-O., Brige, P., Chopinet, S., Poitevin, S. A.-O., Crini, C., Brunet, P., Dignat-george, F., Burtey, S., Guillet, B. &Hache, G. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction. 3.Chang, F.-Y., Chen, P.-A., Siao, W.-H. &Chen, Y.-C. 2023. Sequential provocation of Ekbom’ s syndrome and acute mania following AstraZeneca COVID-19 vaccination. Asian Journal of Psychiatry, 83, 103569 - 103569. 4.Mansour, K., Chadli, Z., Ghachem, I., Fredj, N. B., Romdhane, H. B., Fadhel, N. B., Boughatas, N., Aouam, K., Chaabane, A. &Younes, S. 2023. Seronegative acute encephalitis following COVID-19 vaccines: a case series of an overlooked diagnosis with literature review. Eur J Clin Pharmacol, 79, 975-987. 5.Siao, W.-H., Chang, F.-Y. &Chen, Y.-C. 2023. Memantine treats psychosis and agitation associated with Moderna COVID-19 vaccine. Schizophrenia Research, 255, 14 - 16. 6.Vore, A. S. &Deak, T. Alcohol, inflammation, and blood-brain barrier function in health and disease across development.

Authors

Institutions

Publication Details

Journal
The International Journal of Neuropsychopharmacology
Published
2025-02-01
DOI
https://doi.org/10.1093/ijnp/pyae059.219
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

RECURRENT PSYCHOTIC EPISODES FOLLOWING COVID-19 VACCINATION: A CASE REPORT

Wen-Huei Siao
1 links
The International Journal of Neuropsychopharmacology
SARS-CoV-2 and COVID-19 Research
article

RECURRENT PSYCHOTIC EPISODES FOLLOWING COVID-19 VACCINATION: A CASE REPORT

Wen-Huei Siao
article en

Abstract

Abstract Background Acute neuropsychiatric symptoms induced by COVID-19 vaccination have been reported in several cases. Limbic encephalitis stands as one of the differential diagnoses due to its varied manifestations and etiologies making the diagnosis more challenging. Aims & Objectives We present a case that experienced recurrent brief psychotic symptoms and behavior changes with positive image findings following multiple doses of the Moderna COVID vaccine suggesting limbic encephalitis as a potential differential diagnosis. Method We present a case of a 55-year-old man with a history of end-stage renal disease undergoing hemodialysis, and a history of heavy daily alcohol consumption abstaining for 10 years. After receiving the first dose of the Moderna COVID vaccine, he developed acute onset psychotic symptoms characterized by grandiose delusions, vivid auditory and visual hallucinations, and hearing conversations about his alleged past life as a great poet from the 17th century who authored an enduring masterpiece. He remained capable of self-care but exhibited self-talking behaviors. The symptoms completely resolved within 2 weeks without any medication. The patient attributed the symptoms to a spiritual experience and continued to receive subsequent vaccine doses. These symptoms recurred in the same pattern lasting 2-4 weeks after receiving the second and third doses of the Moderna vaccine one month and five months after the initial dose. Around 6 months after the last dose, the patient experienced a similar recurrence of psychotic symptoms, with behavior disturbances which were accident proneness by self-talking on a busy road. A mild, non-febrile upper respiratory tract infection was identified as a possible triggering factor, with normal blood tests. A brain magnetic resonance imaging revealed some old lacunar infarctions and symmetric hyperintensities in the mesial temporal lobe on T2 FLAIR. CSF showed normal in routine analysis and EEG was unremarkable. He demonstrated complete orientation and focused conversation but continued to experience auditory hallucinations and remained firmly convinced of his delusions upon psychiatric visit without focal neurologic signs or abnormal movements. Serum and CSF autoantibody testing were declined and he received treatment with risperidone 1mg per day. The symptoms completely disappeared one week later. Discussion & Conclusion Psychosis following COVID vaccination has been previously reported, but recurrent episodes after each administration have not been documented. Possible mechanisms may involve cytokines crossing the blood-brain barrier leading to acute neuroinflammation. The image findings and the polyphasic course make limbic encephalopathy the primary consideration of differential diagnoses. COVID vaccine-related autoimmune encephalitis has been reported but only in cases with a single episode. Other differential diagnoses to consider include acute disseminated encephalomyelitis (ADEM), and reversible cerebral vasoconstriction syndrome but lacks corresponding imaging evidence. References 1Albsheer, K., Fadul, A., Abdalla, E., Mohamed, G., Elawad, M. Zafar, A. 2022. Post-COVID-19 Vaccine Limbic Encephalitis: A Case Report. Cureus, 14, e29003. 2.Bobot, M. A.-O., Thomas, L., Moyon, A., Fernandez, S., McKay, N., Balasse, L., Garrigue, P. A.-O., Brige, P., Chopinet, S., Poitevin, S. A.-O., Crini, C., Brunet, P., Dignat-george, F., Burtey, S., Guillet, B. &Hache, G. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction. 3.Chang, F.-Y., Chen, P.-A., Siao, W.-H. &Chen, Y.-C. 2023. Sequential provocation of Ekbom’ s syndrome and acute mania following AstraZeneca COVID-19 vaccination. Asian Journal of Psychiatry, 83, 103569 - 103569. 4.Mansour, K., Chadli, Z., Ghachem, I., Fredj, N. B., Romdhane, H. B., Fadhel, N. B., Boughatas, N., Aouam, K., Chaabane, A. &Younes, S. 2023. Seronegative acute encephalitis following COVID-19 vaccines: a case series of an overlooked diagnosis with literature review. Eur J Clin Pharmacol, 79, 975-987. 5.Siao, W.-H., Chang, F.-Y. &Chen, Y.-C. 2023. Memantine treats psychosis and agitation associated with Moderna COVID-19 vaccine. Schizophrenia Research, 255, 14 - 16. 6.Vore, A. S. &Deak, T. Alcohol, inflammation, and blood-brain barrier function in health and disease across development.

The International Journal of NeuropsychopharmacologyVol. 28(Supplement_1)
Taipei Tzu Chi Hospital (TW), Buddhist Tzu Chi Medical Foundation (US)
Openalex Percentile: Top 96%
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.